ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer

Emre Koca, Polly Ann Niravath, Joe Ensor, Tejal Amar Patel, Xiaoxian Li, Pej Hemati, Helen Wong, Wei Qian, Toniva Boone, Jing Zhao, Priya V. Ramshesh, Adam Louis Cohen, Asha Murthy, Sindhu Nair, Jorge German Darcourt, Anna Belcheva, Virginia G. Kaklamani, Jenny Chee Ning Chang

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences